MML Investors Services’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$16.3M Sell
36,607
-4,448
-11% -$1.98M 0.05% 381
2025
Q1
$19.9M Buy
41,055
+4,836
+13% +$2.34M 0.07% 297
2024
Q4
$14.6M Sell
36,219
-11,858
-25% -$4.78M 0.05% 352
2024
Q3
$22.4M Buy
48,077
+10,437
+28% +$4.85M 0.08% 245
2024
Q2
$17.6M Sell
37,640
-3,875
-9% -$1.82M 0.07% 270
2024
Q1
$17.4M Buy
41,515
+2,338
+6% +$977K 0.07% 276
2023
Q4
$15.9M Buy
39,177
+6,186
+19% +$2.52M 0.07% 265
2023
Q3
$11.5M Buy
32,991
+8,059
+32% +$2.8M 0.06% 302
2023
Q2
$8.77M Buy
24,932
+4,229
+20% +$1.49M 0.05% 355
2023
Q1
$6.52M Sell
20,703
-3,113
-13% -$981K 0.05% 374
2022
Q4
$6.88M Buy
23,816
+2,441
+11% +$705K 0.05% 397
2022
Q3
$6.19M Buy
21,375
+400
+2% +$116K 0.05% 388
2022
Q2
$5.91M Buy
20,975
+2,280
+12% +$643K 0.04% 376
2022
Q1
$4.88M Buy
18,695
+5,833
+45% +$1.52M 0.03% 455
2021
Q4
$2.82M Buy
12,862
+1,729
+16% +$380K 0.02% 619
2021
Q3
$2.02M Buy
11,133
+143
+1% +$25.9K 0.02% 722
2021
Q2
$2.22M Sell
10,990
-6,282
-36% -$1.27M 0.02% 673
2021
Q1
$3.71M Buy
17,272
+1,381
+9% +$297K 0.04% 437
2020
Q4
$3.76M Buy
15,891
+2,603
+20% +$615K 0.04% 385
2020
Q3
$3.62M Sell
13,288
-374
-3% -$102K 0.05% 345
2020
Q2
$3.97M Buy
13,662
+6,947
+103% +$2.02M 0.05% 307
2020
Q1
$1.6M Buy
6,715
+1,352
+25% +$322K 0.03% 479
2019
Q4
$1.17M Buy
5,363
+1,170
+28% +$256K 0.02% 662
2019
Q3
$710K Sell
4,193
-689
-14% -$117K 0.01% 817
2019
Q2
$895K Buy
4,882
+852
+21% +$156K 0.01% 757
2019
Q1
$741K Buy
4,030
+469
+13% +$86.2K 0.01% 830
2018
Q4
$590K Sell
3,561
-206
-5% -$34.1K 0.01% 829
2018
Q3
$726K Buy
3,767
+1,179
+46% +$227K 0.01% 811
2018
Q2
$440K Buy
2,588
+288
+13% +$49K 0.01% 903
2018
Q1
$375K Sell
2,300
-109
-5% -$17.8K 0.01% 970
2017
Q4
$361K Sell
2,409
-1,664
-41% -$249K 0.01% 1003
2017
Q3
$619K Buy
4,073
+2,185
+116% +$332K 0.01% 697
2017
Q2
$243K Sell
1,888
-53
-3% -$6.82K ﹤0.01% 1091
2017
Q1
$212K Buy
+1,941
New +$212K ﹤0.01% 718